Circulating Tumor DNA is Unreliable to Detect Somatic Gene Alterations in Gastrointestinal Peritoneal Carcinomatosis

INTRODUCTION: Tumor agnostic circulating tumor DNA (ctDNA) is routinely used to guide treatment decisions in gastrointestinal (GI) cancers, especially metastatic cancers. The amount of ctDNA detected in plasma is affected by stage, tumor burden, and tumor vascularization. We hypothesized that perito...

Descripción completa

Detalles Bibliográficos
Autores principales: Sullivan, Brittany G., Lo, Angelina, Yu, Jingjing, Gonda, Amber, Dehkordi-Vakil, Farideh, Dayyani, Farshid, Senthil, Maheswari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Gastrointestinal Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726669/
https://www.ncbi.nlm.nih.gov/pubmed/35980549
http://dx.doi.org/10.1245/s10434-022-12399-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726669/
https://www.ncbi.nlm.nih.gov/pubmed/35980549
http://dx.doi.org/10.1245/s10434-022-12399-y

Ejemplares similares